NCT06435520
Enhancing Hypnotic Medication Discontinuation in Primary Care
At risk: Primary completion moved at least 6 months later, enrollment reduced 42%.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Enrollment reduced: 430 → 250 participants Show 6 more changesShow less
- Primary completion pushed from Jun 30, 2028 to Dec 31, 2028
- Phase changed: Phase 4 → Not applicable
- Eligibility criteria expanded, about 476 words
- Study completion moved earlier from Jun 30, 2029 to Dec 31, 2028
- Study description shortened, about 10 words
- Site contact updated
- Minor Start date changed from estimate of Jul 1, 2025 to Jan 1, 2025v5
- Notable Start date: Jan 1, 2025 to Jul 1, 2025v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Notable Start date: Sep 1, 2024 to Jan 1, 2025v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Hypnotic discontinuation rates
Timeframe: Post-treatment at approximately weeks 22 and 49 of participation
Insomnia remission rates
Timeframe: Post-treatment at approximately weeks 22 and 49 of participation
Arms and interventions
Digital cognitive behavioral therapy combined with structured medication taperingExperimental
dCBTI delivered in tandem with SMT during intervention phase.
Structured medication tapering aloneExperimental
Structured medication tapering delivered alone with general sleep hygiene information.
Behavioral: Digital Cognitive Behavioral Therapy, Structured Medication Tapering
Sites
1 site in 1 country
- National Jewish HealthDenver, Colorado, United States